DKHH Shares Officially Listed, Cipta Sarana Medika Raises Rp69 Billion
PT Cipta Sarana Medika Tbk (DKHH) successfully went public on May 8, 2025, at Rp132 per share, with investor demand overshooting the target by 190 times.
DKHH Officially Listed on the Indonesia Stock Exchange
PT Cipta Sarana Medika Tbk (DKHH), a new entrant in Indonesia’s healthcare sector, officially listed its shares on the Indonesia Stock Exchange (IDX) on May 8, 2025. The company offered its IPO at Rp132 per share, releasing 530 million shares—or 20% of its total issued capital—successfully raising approximately Rp69.96 billion.
Massive Demand, Oversubscribed 190 Times
The IPO received overwhelming investor enthusiasm, recording an oversubscription rate of 190 times in the centralized allotment. Total bids reached Rp3.8 trillion, reflecting strong confidence in DKHH’s growth potential and operational credibility.
IPO Proceeds to Fund Expansion and Equipment
Proceeds from the IPO will be allocated for constructing a new hospital building in DKH Cibadak, renovating existing facilities, and purchasing advanced medical equipment such as CT scanners. A portion of the funds will also go toward supporting operational and working capital needs.
Shares Skyrocket on First Trading Day
On its debut, DKHH shares soared, immediately hitting the Upper Auto Rejection limit with a 34.85% jump to Rp178 per share. Analysts expect this momentum to continue, especially with DKHH’s expansion plans across West Java.
Backed by Prominent Legacy
DKHH is part of a hospital network owned by the family of Umar Wirahadikusumah, Indonesia’s former Vice President (1983–1988). This legacy brings added public trust and credibility to the company’s corporate governance.
DKHH’s successful IPO marks a strong entry into the public market, underpinned by high demand, strategic healthcare investments, and the trust of a respected legacy. With rising demand for quality medical services, DKHH is poised to play a key role in shaping Indonesia’s healthcare transformation.
